Sonja Heibl

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon et al. · Breast Cancer Research · 2021 · 154 citations · Full text

Medicine, Cancer Biology, Oncology +17

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Markus Pfirrmann, Richard E. Clark, Witold Prejzner et al. · Leukemia · 2020 · 95 citations · Full text

Public Health, Biostatistics, Oncology +14

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Lisa Pleyer, Michael Leisch, Alexandra Kourakli et al. · The Lancet Haematology · 2021 · 53 citations

Medicine, Hematology, Oncology +13

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms

C. Pecquet, Nicolas Papadopoulos, Thomas Balligand et al. · Blood · 2022 · 45 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11